|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal of Lipid Research, Vol. 50, S293-S298, April 2009
Lysophospholipid receptors in vertebrate development, physiology, and pathology
Center for Vascular Biology, University of Connecticut Health Center, Farmington, CT 06030 Published, JLR Papers in Press, December 8, 2008.
1 To whom correspondence should be addressed. e-mail: hla{at}nso2.uchc.edu
Lysophospholipid (LP) research has experienced a period of renaissance with the discovery of the lysophosphatidic acid (LPA) and sphingosine 1-phosphate (S1P) receptors in the late 1990s. Vertebrate LP receptors regulate embryogenesis, vascular development, neurogenesis, uterine development, oocyte survival, immune cell trafficking and inflammatory reactions. LP signaling is important in cancer, autoimmunity and inflammatory diseases. Research on LP biology has contributed to the development of a first-generation S1P receptor modulator that has entered phase III clinical trials for the treatment of multiple sclerosis. Further basic research on LP signaling is anticipated to lead to novel therapeutic tools to combat various human diseases.
Supplementary key words sphingosine 1-phosphate lysophosphatidic acid G protein-coupled receptor Abbreviations: LP, lysophospholipid; LPA, lysophosphatidic acid; LPP, lipid phosphate phosphatase; S1P, sphingosine 1-phosphate; SphK, sphingosine kinase
Related Webpages:
This article has been cited by other articles:
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||